Literature DB >> 21892198

Genetic polymorphisms in Kawasaki disease.

Ho-chang Kuo1, Wei-chiao Chang.   

Abstract

Kawasaki disease (KD) is an acute febrile systemic vasculitis, and the cause of KD is not well understood. It is likely due to multiple interactions between genes and environmental factors. The development of genetic association and genome-wide association studies (GWAS) has opened an avenue to better understanding the molecular mechanisms underlying KD. A novel ITPKC signaling pathway was recently found to be responsible for the susceptibility to KD. Furthermore, the GWAS demonstrated the functionally related susceptibility loci for KD in the Caucasian population. In the last decade, the identification of several genomic regions linked to the pathogenesis of KD has made a major breakthrough in understanding the genetics of KD. This review will focus on genetic polymorphisms associated with KD and describe some of the possible clinical implications and molecular mechanisms that can be used to explain how genetic variants regulate the pathogenesis in KD.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21892198      PMCID: PMC4010074          DOI: 10.1038/aps.2011.93

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  77 in total

Review 1.  Kawasaki disease: infection, immunity and genetics.

Authors:  Chih-Lu Wang; Yu-Tsun Wu; Chieh-An Liu; Ho-Chang Kuo; Kuender D Yang
Journal:  Pediatr Infect Dis J       Date:  2005-11       Impact factor: 2.129

2.  [Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children].

Authors:  T Kawasaki
Journal:  Arerugi       Date:  1967-03

Review 3.  [Atypical kawasaki disease: literature review and clinical nursing].

Authors:  Yu-Chen Liu; Chiu-Ping Hou; Chiu-Ming Kuo; Chi-Di Liang; Ho-Chang Kuo
Journal:  Hu Li Za Zhi       Date:  2010-12

4.  Randomized trial of pulsed corticosteroid therapy for primary treatment of Kawasaki disease.

Authors:  Jane W Newburger; Lynn A Sleeper; Brian W McCrindle; L LuAnn Minich; Welton Gersony; Victoria L Vetter; Andrew M Atz; Jennifer S Li; Masato Takahashi; Annette L Baker; Steven D Colan; Paul D Mitchell; Gloria L Klein; Robert P Sundel
Journal:  N Engl J Med       Date:  2007-02-15       Impact factor: 91.245

5.  The CCR5 (-2135C/T) polymorphism may be associated with the development of Kawasaki disease in Korean children.

Authors:  Won Kyoung Jhang; Mi-Jin Kang; Hyun-Seung Jin; Jinho Yu; Byoung-ju Kim; Bong Seong Kim; Jong-Keuk Lee; Eul-Ju Seo; Han-Wook Yoo; In Sook Park; Young Mi Hong; Soo-Jong Hong
Journal:  J Clin Immunol       Date:  2008-07-15       Impact factor: 8.317

6.  STIM1 mutation associated with a syndrome of immunodeficiency and autoimmunity.

Authors:  Capucine Picard; Christie-Ann McCarl; Alexander Papolos; Sara Khalil; Kevin Lüthy; Claire Hivroz; Francoise LeDeist; Frédéric Rieux-Laucat; Gideon Rechavi; Anjana Rao; Alain Fischer; Stefan Feske
Journal:  N Engl J Med       Date:  2009-05-07       Impact factor: 91.245

7.  The relationship of eosinophilia to intravenous immunoglobulin treatment failure in Kawasaki disease.

Authors:  Ho-Chang Kuo; Kuender D Yang; Chi-Di Liang; Chin-Nam Bong; Hong-Ren Yu; Lin Wang; Chih-Lu Wang
Journal:  Pediatr Allergy Immunol       Date:  2007-06       Impact factor: 6.377

Review 8.  Susceptibility genes for Kawasaki disease: toward implementation of personalized medicine.

Authors:  Akira Hata; Yoshihiro Onouchi
Journal:  J Hum Genet       Date:  2009-01-16       Impact factor: 3.172

9.  The IL-10 (-627 A/C) promoter polymorphism may be associated with coronary aneurysms and low serum albumin in Korean children with Kawasaki disease.

Authors:  Hyun-Seung Jin; Hyo Bin Kim; Bong Seong Kim; Jong-Keuk Lee; Eul-Ju Seo; Han-Wook Yoo; In Sook Park; Young Mi Hong; Soo-Jong Hong
Journal:  Pediatr Res       Date:  2007-05       Impact factor: 3.756

10.  Ca2+ influx through CRAC channels activates cytosolic phospholipase A2, leukotriene C4 secretion, and expression of c-fos through ERK-dependent and -independent pathways in mast cells.

Authors:  Wei-Chiao Chang; Charmaine Nelson; Anant B Parekh
Journal:  FASEB J       Date:  2006-10-03       Impact factor: 5.191

View more
  22 in total

1.  Meta-analysis of the relationship between single nucleotide polymorphism rs72689236 of caspase-3 and Kawasaki disease.

Authors:  Yanlin Xing; Hong Wang; Xiaomei Liu; Xianyi Yu; Rui Chen; Ce Wang; Xuexin Yu; Le Sun
Journal:  Mol Biol Rep       Date:  2014-07-03       Impact factor: 2.316

2.  Discovery and structural optimization of 1-phenyl-3-(1-phenylethyl)urea derivatives as novel inhibitors of CRAC channel.

Authors:  Hai-zhen Zhang; Xiao-lan Xu; Hua-yan Chen; Sher Ali; Dan Wang; Jun-wei Yu; Tao Xu; Fa-jun Nan
Journal:  Acta Pharmacol Sin       Date:  2015-08-10       Impact factor: 6.150

3.  Erythema and induration of the Bacillus Calmette-Guérin site for diagnosing Kawasaki disease.

Authors:  Ann Loh; Phek Hui Jade Kua; Ze Lei Tan
Journal:  Singapore Med J       Date:  2018-07-16       Impact factor: 1.858

4.  FCGR2A Promoter Methylation and Risks for Intravenous Immunoglobulin Treatment Responses in Kawasaki Disease.

Authors:  Ho-Chang Kuo; Yu-Wen Hsu; Mei-Shin Wu; Peng Yeong Woon; Henry Sung-Ching Wong; Li-Jen Tsai; Ruo-Kai Lin; Sukhontip Klahan; Kai-Sheng Hsieh; Wei-Chiao Chang
Journal:  Mediators Inflamm       Date:  2015-05-18       Impact factor: 4.711

5.  Kawasaki disease and subsequent risk of allergic diseases: a population-based matched cohort study.

Authors:  Ho-Chang Kuo; Wei-Chiao Chang; Kuender D Yang; Hong-Ren Yu; Chih-Lu Wang; Shu-Chen Ho; Chun-Yuh Yang
Journal:  BMC Pediatr       Date:  2013-03-23       Impact factor: 2.125

6.  Sonographic gallbladder abnormality is associated with intravenous immunoglobulin resistance in Kawasaki disease.

Authors:  Chih-Jen Chen; Fu-Chen Huang; Mao-Meng Tiao; Ying-Hsien Huang; Li-Yan Lin; Hong-Ren Yu; Kuender D Yang; Yi-Chuan Huang; Chih-Cheng Chen; Wei-Chiao Chang; Ho-Chang Kuo
Journal:  ScientificWorldJournal       Date:  2012-06-18

Review 7.  Kawasaki disease: pathophysiology, clinical manifestations, and management.

Authors:  Victoria R Dimitriades; Amanda G Brown; Abraham Gedalia
Journal:  Curr Rheumatol Rep       Date:  2014-06       Impact factor: 4.686

8.  Gene-Gene Associations with the Susceptibility of Kawasaki Disease and Coronary Artery Lesions.

Authors:  Ho-Chang Kuo; Jen-Chieh Chang; Mindy Ming-Huey Guo; Kai-Sheng Hsieh; Deniz Yeter; Sung-Chou Li; Kuender D Yang
Journal:  PLoS One       Date:  2015-11-30       Impact factor: 3.240

9.  Increased risk of atopic dermatitis in preschool children with kawasaki disease: a population-based study in taiwan.

Authors:  Peng Yeong Woon; Wei Chiao Chang; Chi-Cheng Liang; Chun Hung Hsu; Sukhontip Klahan; Ying-Hsien Huang; Wei-Pin Chang; Ho-Chang Kuo
Journal:  Evid Based Complement Alternat Med       Date:  2013-08-27       Impact factor: 2.629

10.  A replication study for association of ITPKC and CASP3 two-locus analysis in IVIG unresponsiveness and coronary artery lesion in Kawasaki disease.

Authors:  Ho-Chang Kuo; Yu-Wen Hsu; Chung-Min Wu; Shawn Hsiang-Yin Chen; Kuo-Sheng Hung; Wei-Pin Chang; Kuender D Yang; Kai-Sheng Hsieh; Wei-Chiao Chen; Yoshihiro Onouchi; Wei-Chiao Chang
Journal:  PLoS One       Date:  2013-07-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.